Envista Holdings (NVST) Other Accumulated Expenses (2018 - 2026)
Envista Holdings (NVST) recorded quarterly Other Accumulated Expenses of $577.9 million in Q2 2026, down 7.09% quarter-over-quarter from $622.0 million in Q4 2025, and up 3.42% on a YoY basis from $558.8 million in Q2 2025.
Envista Holdings (NVST) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
Envista Holdings' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $577.9 million for Q2 2026.
- In Q2 2026, Other Accumulated Expenses rose 3.42% year-over-year to $577.9 million; the TTM figure through Apr 2026 stood at $577.9 million (up 3.42% YoY), while the FY2025 annual figure was $622.0 million, up 12.36% from the prior year.
- Other Accumulated Expenses was $577.9 million for Q2 2026 at Envista Holdings, down from $622.0 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $626.5 million in Q3 2025 to a low of $423.6 million in Q1 2023.
- Historically, Other Accumulated Expenses has averaged $516.8 million across 5 years, with a median of $539.4 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses retreated 21.76% in 2023, then advanced 24.83% in 2024.
- A 5-year view of Other Accumulated Expenses shows it stood at $471.4 million in 2022, then declined by 3.33% to $455.7 million in 2023, then climbed by 21.48% to $553.6 million in 2024, then advanced by 12.36% to $622.0 million in 2025, then dropped by 7.09% to $577.9 million in 2026.
- The last three Other Accumulated Expenses figures came in at $577.9 million (Q2 2026), $622.0 million (Q4 2025), and $626.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 577.90 Mn |
| Dec 31, 2025 | 622.00 Mn |
| Sep 26, 2025 | 626.50 Mn |
| Jun 27, 2025 | 586.00 Mn |
| Mar 28, 2025 | 558.80 Mn |
| Dec 31, 2024 | 553.60 Mn |
| Sep 27, 2024 | 541.40 Mn |
| Jun 28, 2024 | 498.80 Mn |
| Mar 29, 2024 | 458.60 Mn |
| Dec 31, 2023 | 455.70 Mn |
| Sep 29, 2023 | 433.70 Mn |
| Jun 30, 2023 | 434.00 Mn |
| Mar 31, 2023 | 423.60 Mn |
| Dec 31, 2022 | 471.40 Mn |
| Sep 30, 2022 | 462.50 Mn |
| Jul 1, 2022 | 539.40 Mn |
| Apr 1, 2022 | 541.40 Mn |
| Dec 31, 2021 | 562.30 Mn |
| Oct 1, 2021 | 509.90 Mn |
| Jul 2, 2021 | 504.80 Mn |